Insider Holders & Insider Ownership - Apellis Pharmaceuticals Inc. (APLS)

List of insiders holdings for Apellis Pharmaceuticals Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
1Morningside Venture Investments Ltd
10% Owner		2022-02-14 16:05:1112,806,342
0		12,806,342Form 13G
2Potentia Holdings LLC
10% Owner		2018-02-07 18:59:553,826,601
0		3,826,601Form 13G
3Cormorant Asset Management LLC
Chen Bihua
Cormorant Global Healthcare GP LLC
Cormorant Global Healthcare Master Fund LP
10% Owner		2020-02-14 16:07:262,700,000
0		2,700,000Form 13G
4Cormorant Asset Management LLC
Cormorant Global Healthcare Master Fund LP
CORMORANT PRIVATE HEALTHCARE FUND I LP
Chen Bihua
10% Owner		2020-02-14 16:07:262,700,000
0		2,700,000Form 13G
5AJU IB Investment Co. Ltd.
10% Owner		2017-11-13 16:29:470
2,292,062		2,292,062Form 4
6Hillhouse Capital Management Ltd.
10% Owner		2019-02-14 15:15:042,098,581
0		2,098,581Form 13G
7venBio Global Strategic Fund II L.P.
10% Owner		2019-02-14 08:50:471,790,102
0		1,790,102Form 13G
8Francois Cedric
Chief Executive Officer		2025-08-29 16:19:34331,605
1,314,422		1,646,027Form 4
9GELLERT MICHAEL E
10% Owner		2017-11-13 16:25:54943,989
0		943,989Form 4
10Machiels Alec
Director		2025-01-03 16:23:44388,227
411,950		800,177Form 4
11Sullivan Timothy Eugene
Chief Financial Officer		2025-09-10 16:02:24353,839
60,396		414,235Form 4
12Axon Steven
Chief Business Officer		2018-11-15 20:40:03398,499
0		398,499Form 4
13Dunlop A. Sinclair
Director		2025-01-03 16:17:32169,592
100,000		269,592Form 4
14Watson David O.
General Counsel		2025-09-12 16:01:04123,730
60,136		183,866Form 4
15MELTZER LESLIE
Chief Research and Development		2025-09-02 10:13:46154,396
0		154,396Form 4
16Boucher Kelley
Chief People Officer		2025-09-03 11:55:16143,424
0		143,424Form 4
17SCHEIBLER LUKAS
Chief Research Officer		2023-12-05 19:40:46107,690
0		107,690Form 4
18Grossi Federico
Chief Medical Officer		2023-01-09 19:02:3694,884
0		94,884Form 4
19Townsend Adam J.
Chief Commercial Officer		2025-01-30 12:18:2284,050
0		84,050Form 4
20Nicholson Nur
Chief Technical Officer		2025-06-11 16:24:1082,500
0		82,500Form 4
21Deschatelets Pascal
Chief Scientific Officer		2025-06-11 16:19:1382,500
0		82,500Form 4
22Baumal Caroline
Chief Medical Officer		2025-06-11 16:16:5182,500
0		82,500Form 4
23DeLong Mark Jeffrey
Chief Business & Strat Officer		2025-06-11 16:10:2382,500
0		82,500Form 4
24Lewis Karen
Chief People Officer		2025-01-30 12:12:0370,251
0		70,251Form 4
25Eisele Jeffrey
Chief Development Officer		2025-01-30 12:10:4355,312
0		55,312Form 4
26Chopas James George
VP/Chief Accounting Officer		2025-09-03 13:06:2853,657
0		53,657Form 4
27WHEELER CRAIG A
Director		2025-04-21 16:23:0144,678
0		44,678Form 4
28Celona Lucia
See Remarks		2020-02-12 16:58:2636,488
0		36,488Form 4
29FONTEYNE PAUL R.
Director		2025-01-03 16:19:3933,904
0		33,904Form 4
30O'Brien Stephanie Monaghan
Director		2025-01-03 16:25:2428,904
0		28,904Form 4
31Chan Gerald
Director		2025-01-03 16:12:4128,904
0		28,904Form 4
32Walbert Keli
Director		2025-01-10 17:39:2624,478
0		24,478Form 4
33Lackner Thomas A.
See Remarks		2020-02-12 16:50:3524,075
0		24,075Form 4
34Brown Victoria L.
Program Team Lead		2023-01-24 16:57:3223,556
0		23,556Form 4
35Sadr Ahmad
See Remarks		2020-02-12 16:46:3019,075
0		19,075Form 4
36Perry Nicole D
Vice President - Accounting		2021-08-03 16:23:5911,008
0		11,008Form 4